Bionexus Gene Lab Corp (BGLC) Stock Price & Analysis

Bionexus Gene Lab Corp (BGLC) rose 0.00% to USD 1.51 as of July 25, 2026 at 03:09 UTC, according to Nexqual real-time market data.

BGLC last closed at USD 1.51; the session ranged USD 1.5–1.55 on volume of 4,752 shares. Market capitalization is —, with a 52-week range of USD 1.07–8.98 (NCM). Source: Nexqual, July 25, 2026 at 03:09 UTC.

Key Statistics (as of July 25, 2026 at 03:09 UTC)

Technical Analysis (BGLC)

Nexqual's technical model rates BGLC "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:09 UTC.

From Bionexus Gene Lab Corp's Latest SEC 10-K Filing (filed 2026-04-14)

Key Strengths & Strategy (as disclosed to the SEC)

• Our proprietary algorithm software then analyzes this collected data and processes checked by the laboratory manager to ensure all the steps are followed in the deriving predictive model for each disease condition.
• By identifying disease-specific gene activity patterns, we can develop screening tools that enable early detection, monitor disease progression, and support precision interventions.   We take advantage of profiling these changes, which enables us to identify unique molecular signatures (biomarkers) reflecting disease activity which can then be used to develop disease-specific molecular diagnostic assays.

Partnerships

• MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management.   In November 2025, the Company entered into a Share Subscription and Shareholders' Agreement with Fidelion Diagnostics Pte.
• The Company continues to evaluate MRNA Scientific's operations, commercial opportunities, and strategic direction.   In November 2025, the Company completed a Share Subscription and Shareholders' Agreement with Fidelion Diagnostics Pte.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:09 UTC. This page is informational and not investment advice.